The ArQule team has a successful track record of both in-licensing and out-licensing programs and technologies. The ArQule team has conducted multiple successful collaborations spanning the U.S., EU and Asia, and is an experienced partner-of-choice in oncology.
With five drug candidates in the clinic and multiple clinical trials ongoing, ArQule has a proven track record for successful clinical development. We actively consider both the partnering of our own proprietary programs and the in-licensing or acquisition of new programs as part of our business strategy.
If you’d like to learn more about partnering opportunities at ArQule, please contact us via email.